Abstract:BackgroundThe first etanercept biosimilar was approved by the European Commission in January 2016. Of the 27,000 patients* estimated to be treated with etanercept biosimilar in the Europe, 5,122 patients* are estimated to be on the etanercept biosimilar in Germany at the end of the analysis period. Its usage in Europe may support healthcare sustainability by reducing costs, thereby relieving the burden on healthcare budgets and improving patient's ability to get the right care at the right time.ObjectivesThe a… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.